Literature DB >> 17721030

Thirty-day outcomes of direct carotid artery stenting with cerebral protection in high-risk patients.

Josef Veselka1, Daniela Cerná, Petra Zimolová, Peter Blasko, Jirí Fiedler, Petr Hájek, Martin Maly, David Zemánek, Radka Duchonová.   

Abstract

BACKGROUND: Implantation of a carotid artery stent after predilation is a standard approach in the endovascular treatment of carotid artery stenoses. Stenting without predilation may be an alternative approach in a certain subset of patients. The present prospective, single-center registry was designed to evaluate the feasibility and safety of direct carotid artery stenting (DCAS) in high-risk patients. METHODS AND
RESULTS: Symptomatic patients with stenosis >50% and asymptomatic patients with stenosis >70% were eligible for enrolment. Criteria for high-risk patients included: need or history of open heart surgery, history of myocardial infarction, multivessel coronary artery disease, left ventricular dysfunction (ejection fraction < or =40%), severe pulmonary or renal disease, significant contralateral carotid disease, previous endarterectomy, and age > or =80 years. All procedures were performed using a filter protection device. Patients underwent complete clinical examination before and after DCAS and at 30-day follow-up. A total of 83 consecutive patients (45 males, 68+/-9 years, 33% symptomatic) underwent 100 procedures and 103 stents were deployed successfully. The technical success rate of stenting was 100%. Predilation of carotid stenosis was necessary in 1 (1%) procedure. Carotid-artery stenoses before and after DCAS were 80+/-9% and 7+/-9%, respectively. The median fluoroscopic time for DCAS was 7 min. The overall rate of in-hospital major adverse cerebrovascular events (death, stroke, myocardial infarction) was 5% (2 minor strokes, 3 transient attacks). There was 1 (1%) minor stroke within the 30-day follow-up.
CONCLUSION: DCAS is feasible and can be performed with an acceptable risk in high-risk patients.

Entities:  

Mesh:

Year:  2007        PMID: 17721030     DOI: 10.1253/circj.71.1468

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

Review 1.  Carotid Artery Stenting-Historical Context, Trends, and Innovations.

Authors:  Miloslav Spacek; Josef Veselka
Journal:  Int J Angiol       Date:  2015-08-19

2.  Atherosclerotic Plaque Composition Is Still an Almost Unrecognized Factor of Risk Stratification in Patients with Carotid Artery Disease.

Authors:  Josef Veselka
Journal:  Int J Angiol       Date:  2015-06-05

3.  Near-infrared spectroscopy combined with intravascular ultrasound in carotid arteries.

Authors:  Cyril Štěchovský; Petr Hájek; Martin Horváth; Miloslav Špaček; Josef Veselka
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-05       Impact factor: 2.357

4.  Carotid artery stenting in asymptomatic and surgically high-risk patients: single-centre, single-operator results.

Authors:  Josef Veselka; Petra Zimolová; Daniela Cerná; Pavel Stanka; Aleš Tomek; Martin Srámek
Journal:  Int J Angiol       Date:  2008

5.  Comparison of mid-term outcomes of carotid artery stenting for moderate versus critical stenosis.

Authors:  Josef Veselka; Petra Zimolová; Lucie Martinkovičová; Pavol Tomašov; Petr Hájek; Martin Malý; Miloslav Spaček; David Zemánek; David Tesař
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

6.  Carotid artery stenting - current status of the procedure.

Authors:  Miloslav Spacek; Josef Veselka
Journal:  Arch Med Sci       Date:  2013-11-29       Impact factor: 3.318

7.  Impact of coexisting multivessel coronary artery disease on short-term outcomes and long-term survival of patients treated with carotid stenting.

Authors:  Josef Veselka; Miloslav Špaček; Martin Horváth; Cyril Štěchovský; Ingrid Homolová; Petra Zimolová; Petr Hájek
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

8.  Long-term survival of carotid stenting patients with regard to single- or double-vessel carotid artery disease: a propensity score matching analysis.

Authors:  Josef Veselka; Petr Hajek; Cyril Štěchovský; Martin Horváth; Radka Adlová; Robert Roland; Ingrid Homolová; Eva Hansvenclová; Petra Zimolová
Journal:  Arch Med Sci       Date:  2020-08-17       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.